Skip to main content
OpenTrials

Clinical trial condition

Attention Deficit and Disruptive Behavior Disorders

Explore clinical trials studying Attention Deficit and Disruptive Behavior Disorders. Study availability and eligibility vary by location and protocol.

1,451 public trials 169 recruiting studies
Refine in advanced search Browse all conditions

Attention Deficit and Disruptive Behavior Disorders trial results

Completed

Efficacy and Safety of Lisdexamfetamine Dimesylate (LDX) in Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD)

NCT00735371

Conditions
Attention Deficit Disorder with Hyperactivity, Attention Deficit Hyperactivity Disorder (ADHD), Attention Deficit and Disruptive Behavior Disorders, +2 more
Locations
  • Clinical Study Centers, LLC Little Rock, Arkansas, United States
  • Valley Clinical Research, Inc. El Centro, California, United States
  • Peninsula Research Associates, Inc Rolling Hills Estates, California, United States
  • Psychiatric Centers at San Diego (PCSD-Feighner Research Institute) San Diego, California, United States
View all 45 locations
View Trial Details
Completed

Efficacy and Safety of SPD503 in Combination With Psychostimulants

NCT00734578

Conditions
ADHD, Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, +2 more
Locations
  • Harmonex Neuroscience Research Dothan, Alabama, United States
  • Melmed Center Scottsdale, Arizona, United States
  • Clinical Study Centers, LLC Little Rock, Arkansas, United States
  • Valley Clinical Research, Inc. El Centro, California, United States
View all 61 locations
View Trial Details
Completed

A Classroom Study to Assess the Time of Onset of Vyvanse (Lisdexamfetamine Dimesylate) in Pediatric Subjects Aged 6-12 With Attention Deficit/Hyperactivity Disorder (ADHD)

NCT00500149

Conditions
ADHD, Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, +2 more
Locations
  • Clinical Study Centers, LLC Little Rock, Arkansas, United States
  • Univ. of CA, Irvine Child Development Center Irvine, California, United States
  • Shire Clinical Research Site Wildomar, California, United States
  • Vince and Associates Clinical Research Overland Park, Kansas, United States
View Trial Details
Completed

SPD503 (Guanfacine Hydrochloride) in ADHD Plus Oppositional Symptoms

NCT00367835

Conditions
ADHD, Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, +2 more
Locations
  • HOPE Research Institute Phoenix, Arizona, United States
  • Valley Clinical Research El Centro, California, United States
  • Peninsula Research Associates Inc Rolling Hills Estates, California, United States
  • Sarkis Clinical Trials Gainesville, Florida, United States
View all 34 locations
View Trial Details
Completed

Maintenance of Efficacy of Extended-Release Guanfacine HCl in Children and Adolescents With Attention-deficit/Hyperactivity Disorder (ADHD)

NCT01081145

Conditions
Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, Attention-Deficit/Hyperactivity Disorder, +2 more
Locations
  • Harmonex Neuroscience Research Dothan, Alabama, United States
  • Clinical Study Centers, LLC Little Rock, Arkansas, United States
  • Psychiatric Centers at San Diego, Feighner Research San Diego, California, United States
  • Encompass Clinical Research - North Coast Spring Valley, California, United States
View all 81 locations
View Trial Details
Completed

Randomized, Double-blind Safety and Efficacy Study of Lisdexamfetamine Dimesylate (LDX) in Children and Adolescents Aged 6-17

NCT00763971

Conditions
ADHD, Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, +2 more
Locations
  • ZiekenhuisNetwerk Antwerpen, Commandant Weynsstraat 165, Campus Hoge Beuken Hoboken, Antwerp, Belgium
  • Universitair Ziekenhuis Gent, Kinder-en Jeugdpsychiatrie, De Pintelaan 185 Ghent, East Flanders, Belgium
  • Afdeling Psychiatrie, UZ Herestraat 49, Bus 07003 Leuven, Belgium
  • Hospital Archet 2 Nice, Cedex 03, France
View all 49 locations
View Trial Details
Completed

Vyvanse Adolescent Open-Label Safety and Efficacy Extension Study

NCT00764868

Conditions
ADHD, Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, +2 more
Locations
  • Clinical Study Centers, LLC Little Rock, Arkansas, United States
  • Valley Clinical Research, Inc. El Centro, California, United States
  • Penninsula Research Associates, Inc. Rolling Hills Estates, California, United States
  • Psychiatric Centers at San Diego (PCSD-Feighner Research Institute) San Diego, California, United States
View all 45 locations
View Trial Details
Completed

Comparison of Lisdexamfetamine Dimesylate With Atomoxetine HCl in Attention-Deficit/Hyperactivity Disorder (ADHD) Subjects With an Inadequate Response to Methylphenidate

NCT01106430

Conditions
Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, Attention-Deficit/Hyperactivity Disorder, +2 more
Locations
  • Harmonex Neuroscience Research, Inc Dothan, Alabama, United States
  • Clinical Study Centers, LLC Little Rock, Arkansas, United States
  • Shanti Clinical Trials Colton, California, United States
  • Psychiatric Centers at San Diego Feighner Research San Diego, California, United States
View all 64 locations
View Trial Details

Related conditions